These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9391746)

  • 1. Pharmacokinetic changes during pregnancy and their clinical relevance.
    Loebstein R; Lalkin A; Koren G
    Clin Pharmacokinet; 1997 Nov; 33(5):328-43. PubMed ID: 9391746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
    Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
    Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs in human milk. Clinical pharmacokinetic considerations.
    Atkinson HC; Begg EJ; Darlow BA
    Clin Pharmacokinet; 1988 Apr; 14(4):217-40. PubMed ID: 3292101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation.
    Anderson GD
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):947-60. PubMed ID: 17125410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug kinetics in pregnancy.
    Krauer B; Krauer F
    Clin Pharmacokinet; 1977; 2(3):167-81. PubMed ID: 328205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug disposition and effects in the fetus.
    Rurak DW; Wright MR; Axelson JE
    J Dev Physiol; 1991 Jan; 15(1):33-44. PubMed ID: 1678754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
    Anderson GD
    Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.
    Guay J; Grenier Y; Varin F
    Clin Pharmacokinet; 1998 Jun; 34(6):483. PubMed ID: 9646009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats.
    Hinderliter PM; Mylchreest E; Gannon SA; Butenhoff JL; Kennedy GL
    Toxicology; 2005 Jul; 211(1-2):139-48. PubMed ID: 15863257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications.
    Koren G; Pariente G
    Pharm Res; 2018 Feb; 35(3):61. PubMed ID: 29435666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemics: pharmacokinetic considerations during pregnancy.
    Klieger C; Pollex E; Kazmin A; Koren G
    Ther Drug Monit; 2009 Oct; 31(5):533-41. PubMed ID: 19730277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs in pregnancy. Pharmacokinetics in pregnancy.
    Dawes M; Chowienczyk PJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):819-26. PubMed ID: 11800526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of drugs in pregnancy.
    Mucklow JC
    Clin Obstet Gynaecol; 1986 Jun; 13(2):161-75. PubMed ID: 2873913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):201-8. PubMed ID: 9079241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of drug kinetics in pregnancy.
    Pavek P; Ceckova M; Staud F
    Curr Drug Metab; 2009 Jun; 10(5):520-9. PubMed ID: 19689248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.